Skip to content

The effect of education based on Pender's Health Promotion Model on quality of life and medication adherence among patients with Implantable Cardioversion Defibrillator

The effect of education based on Pender's Health Promotion Model on quality of life and medication adherence among patients with Implantable Cardioversion Defibrillator

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240309061231N1
Enrollment
66
Registered
2024-04-10
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pender's health promotion model, Quality of life, Medication adherence, Implantable Cardioversion Defibrillator.

Interventions

Intervention 1: Intervention group: The participants will be included in the study through continuous sampling method and according to the inclusion and exclusion criteria, and will be allocated to th

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Ability to read and write An Ejection Fraction over 35% Absence of underlying chronic diseases affecting quality of life including cancer, stroke, chronic kidney disease, severe diabetes mellitus with HbA1C over 7.5 Absence of psychological disorders

Exclusion criteria

Exclusion criteria: Deterioration of the clinical condition in a way that disrupts the participation in the research Not participating in more than two educating sessions

Design outcomes

Primary

MeasureTime frame
The score of quality of life in Minnesota living with heart failure questionnaire (MLHFQ). Timepoint: At the beginning of the study (before the intervention), At the end of the study (two month after the intervention). Method of measurement: Minnesota living with heart failure questionnaire (MLHFQ).;The score of medication adherence in Morisky Medication Adherence Scale (MMAS-8). Timepoint: At the beginning of the study (before the intervention), At the end of the study (two month after the intervention). Method of measurement: Morisky Medication Adherence Scale (MMAS-8).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Ahmadi

Iran University of Medical Sciences

Ahmadiniloo77@gmail.com+98 21 4411 3145

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026